News Announcement

Dishman Pharmaceuticals & Chemicals: Updates

We hereby inform that pursuant to the Scheme of Merger, erstwhile DPCL has been merged into CAIL and subsequently, in terms of the said Scheme, the name of Transferee Company i.e. Carbogen Amcis (India) Ltd. has been changed to Dishman Carbogen Amcis Ltd. ('DCAL') w.e.f. 27th March, 2017.

Pursuant to the merger of DPCL into DCAL, securities of DPCL have been suspended by both BSE and NSE w.e.f. 30th May, 2017 due to procedural reasons. We are in the process of listing the merged entity, DCAL on BSE and NSE.

This is to inform that since the merged entity, DCAL is currently unlisted, the Company is unable to file quarterly compliances as per SEBI (LODR) Regulations, 2015 with the Stock Exchanges for the quarter ended 30th June, 2017.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.